By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


Drug Discovery

Company News
Cytokinetics (CYTK) Announces New Data Presented At The International Symposium On ALS/MND 12/9/2016 6:25:13 AM
Origent And Cytokinetics (CYTK) Present Analyses Demonstrating Baseline Data Predict Measures Of Vital Capacity In Patients With ALS 12/7/2016 7:31:52 AM
Cytokinetics (CYTK) Announces Start Of GALACTIC-HF, A Phase III Clinical Trial Of Omecamtiv Mecarbil 12/1/2016 7:13:58 AM
Amgen (AMGN) And Cytokinetics (CYTK) Release: The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure 12/1/2016 7:10:42 AM
Cytokinetics (CYTK) Announces Publication Relating To Novel Smooth Muscle Myosin Inhibitor 11/7/2016 7:40:24 AM
Cytokinetics (CYTK) Reports Third Quarter 2016 Financial Results 10/28/2016 7:54:09 AM
Cytokinetics (CYTK) Announces First Patient Enrolled In VIGOR-ALS, An Open-Label Extension Clinical Trial Of Tirasemtiv 10/18/2016 7:56:54 AM
Cytokinetics (CYTK) To Announce Third Quarter Results On October 27, 2016 10/17/2016 6:15:24 AM
Cytokinetics (CYTK) Announces Early Termination Of Hart-Scott-Rodino Waiting Period For Expanded Collaboration With Astellas (ALPMY) 9/29/2016 7:43:28 AM
Cytokinetics (CYTK) Announces Presentation Of Additional Results From COSMIC-HF At The HFSA Annual Scientific Meeting 9/19/2016 7:52:13 AM